Literature DB >> 11709116

Clinical evidence for osteoarthritis as an inflammatory disease.

T Pincus1.   

Abstract

Osteoarthritis (OA) is not a simple consequence of "wear and tear" or aging--the presence of cytokines suggests a role for inflammation. OA is polyarticular in most patients, with metabolic and differential risk factors for prevalence and severity. Odds ratios for the prevalence of OA according to formal education levels are similar to those seen for dysregulatory diseases such as hypertension, diabetes, and rheumatoid arthritis. Clinical survey data indicate significant patient preference for nonsteroidal anti-inflammatory drugs (NSAIDs) compared with acetaminophen. A recent crossover clinical trial indicated significantly greater efficacy of the NSAID, diclofenac/misoprostol, versus acetaminophen for most patients with OA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709116     DOI: 10.1007/s11926-001-0068-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.686


  49 in total

Review 1.  The verdict favors nonsteroidal antiinflammatory drugs for treatment of osteoarthritis and a plea for more evidence on other treatments.

Authors:  D T Felson
Journal:  Arthritis Rheum       Date:  2001-07

Review 2.  Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets.

Authors:  J P Pelletier; J Martel-Pelletier; S B Abramson
Journal:  Arthritis Rheum       Date:  2001-06

Review 3.  Social conditions and self-management are more powerful determinants of health than access to care.

Authors:  T Pincus; R Esther; D A DeWalt; L F Callahan
Journal:  Ann Intern Med       Date:  1998-09-01       Impact factor: 25.391

4.  The role of metabolic factors and blood pressure in the association of obesity with osteoarthritis of the knee.

Authors:  M A Davis; W H Ettinger; J M Neuhaus
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

5.  Social class and the major cardiovascular diseases.

Authors:  A Antonovsky
Journal:  J Chronic Dis       Date:  1968-05

Review 6.  Social/economic status and disease.

Authors:  M G Marmot; M Kogevinas; M A Elston
Journal:  Annu Rev Public Health       Date:  1987       Impact factor: 21.981

7.  Most chronic diseases are reported more frequently by individuals with fewer than 12 years of formal education in the age 18-64 United States population.

Authors:  T Pincus; L F Callahan; R V Burkhauser
Journal:  J Chronic Dis       Date:  1987

8.  Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression.

Authors:  J P Caron; J C Fernandes; J Martel-Pelletier; G Tardif; F Mineau; C Geng; J P Pelletier
Journal:  Arthritis Rheum       Date:  1996-09

9.  Relation of education to sudden death after myocardial infarction.

Authors:  E Weinblatt; W Ruberman; J D Goldberg; C W Frank; S Shapiro; B S Chaudhary
Journal:  N Engl J Med       Date:  1978-07-13       Impact factor: 91.245

10.  Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology.

Authors:  M C Hochberg; R D Altman; K D Brandt; B M Clark; P A Dieppe; M R Griffin; R W Moskowitz; T J Schnitzer
Journal:  Arthritis Rheum       Date:  1995-11
View more
  7 in total

1.  Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee--a double-blind prospective randomized study.

Authors:  Naseer M Akhtar; Rizwan Naseer; Abid Z Farooqi; Wajahat Aziz; Mussadeq Nazir
Journal:  Clin Rheumatol       Date:  2004-07-24       Impact factor: 2.980

2.  MR imaging of erosions in interphalangeal joint osteoarthritis: is all osteoarthritis erosive?

Authors:  A J Grainger; J M Farrant; P J O'Connor; A L Tan; S Tanner; P Emery; D McGonagle
Journal:  Skeletal Radiol       Date:  2007-05-12       Impact factor: 2.199

Review 3.  Innate inflammation and synovial macrophages in osteoarthritis pathophysiology.

Authors:  Timothy M Griffin; Carla R Scanzello
Journal:  Clin Exp Rheumatol       Date:  2019-10-15       Impact factor: 4.473

4.  Osteoblasts from osteoarthritis patients show enhanced susceptibility to Ross River virus infection associated with delayed type I interferon responses.

Authors:  Weiqiang Chen; Suan-Sin Foo; Rachel W Li; Paul N Smith; Suresh Mahalingam
Journal:  Virol J       Date:  2014-11-19       Impact factor: 4.099

5.  Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks.

Authors:  Carmelo Scarpignato; Angel Lanas; Corrado Blandizzi; Willem F Lems; Matthias Hermann; Richard H Hunt
Journal:  BMC Med       Date:  2015-03-19       Impact factor: 8.775

6.  No effect of 6-month intake of glucosamine sulfate on Modic changes or high intensity zones in the lumbar spine: sub-group analysis of a randomized controlled trial.

Authors:  Philip Wilkens; Kjersti Storheim; Inger Scheel; Linda Berg; Ansgar Espeland
Journal:  J Negat Results Biomed       Date:  2012-08-17

7.  Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritis.

Authors:  A R Tellegen; I Rudnik-Jansen; B Pouran; H M de Visser; H H Weinans; R E Thomas; M J L Kik; G C M Grinwis; J C Thies; N Woike; G Mihov; P J Emans; B P Meij; L B Creemers; M A Tryfonidou
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.